Anti-DPEP3 antibodies and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9777071
APP PUB NO 20170044271A1
SERIAL NO

15331282

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE STEMCENTRX LLC1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boontanrart, Mandy San Francisco, US 5 9
Liu, David San Francisco, US 263 5445
Rokkam, Deepti Sunnyvale, US 34 18
Saunders, Laura San Francisco, US 50 327

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 3, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00